Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Background: Insulin-like growth factor 2 (IGF2) is a protein hormone known to regulate cell proliferation, growth, migration, differentiation and survival. The gene is parentally imprinted in the sense that transcripts are almost exclusively derived from the paternal allele. Loss of imprinting of the IGF2 gene is a recurrent observation in growth disorders that combine overgrowth with a variety of malignant tumours. Moreover, IGF2 has been proposed to play a role in the development of a variety of seemingly unrelated cancers that play an important role in geriatric medicine, e.g. breast cancer, colon cancer and lung cancer. Finally, IGF2 has been implicated in cardiovascular disease, since, for example, IGF2 has been shown to influence the size of atherosclerotic lesions. Objective: To summarize current knowledge about IGF2, its interactions with binding proteins and receptors and connections with key diseases. Methods: The contents of this paper were based on reviews of existing literature within the field. Results: There is a substantial amount of research linking IGF2 to growth disorders, cancer and to a much lesser degree cardiovascular disease. Some of the studies on IGF2 and tumour growth have yielded conflicting results, for instance regarding its effect on apoptosis. Conclusion: Today, our knowledge on how IGF2 is composed and interacts with receptors has come a long way. However, there is comparatively little information on how IGF2 affects tumour growth and cardiovascular diseases such as atherosclerosis. Thus, further research will be needed to elucidate the impact of IGF2 on key diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genes whose expression significantly decreased include Mki67 and Igf2, which have roles in promoting cellular proliferation40,41.”
From The single-cell transcriptional landscape of mammalian organogenesis (2019) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parental imprinting of the mouse insulin-like growth factor II gene
DeChiara, T. M., Robertson, E. J., & Efstratiadis, A. (1991) · Cell · doi:10.1016/0092-8674(91)90513-x · Cited by 1,783
Rinderknecht, E., & Humbel, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,545
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
SALMON, W. D., & Daughaday, W. H. (1957) · PubMed · Cited by 1,084
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Primary structure of human insulin‐like growth factor II
Rinderknecht, E., & Humbel, R. E. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)80237-3 · Cited by 780
Insulin-like growth factor binding proteins and their role in controlling IGF actions
Clemmons, D. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00053-6 · Cited by 498
Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.
Favelyukis, S., Till, J. H., Hubbard, S. R., & Miller, W. T. (2001) · Nature Structural Biology · doi:10.1038/nsb721 · Cited by 336
IGF2: Epigenetic regulation and role in development and disease
Chao, W., & D’Amore, P. A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.005 · Cited by 336
Cited by
The single-cell transcriptional landscape of mammalian organogenesis
Cao, J., Spielmann, M., Qiu, X., Huang, X., Ibrahim, D. M., Hill, A. J., Zhang, F., Mundlos, S., Christiansen, L., Steemers, F. J., et al. (2019) · Nature · doi:10.1038/s41586-019-0969-x · Cited by 4,490
“Genes whose expression significantly decreased include Mki67 and Igf2, which have roles in promoting cellular proliferation 40,41 .”
The landscape of genomic imprinting across diverse adult human tissues
Baran, Y., Subramaniam, M., Biton, A., Tukiainen, T., Tsang, E. K., Rivas, M. A., Pirinen, M., Gutierrez-Arcelus, M., Smith, K. S., Kukurba, K. R., et al. (2015) · Genome Research · doi:10.1101/gr.192278.115 · Cited by 218
Zacchigna, S., Martinelli, V., Moimas, S., Colliva, A., Anzini, M., Nordio, A., Costa, A., Rehman, M., Vodret, S., Pierro, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04908-z · Cited by 193
Epigenetic regulation of the Igf2/H19 gene cluster
Nordin, M., Bergman, D., Halje, M., Engström, W., & Ward, A. (2014) · Cell Proliferation · doi:10.1111/cpr.12106 · Cited by 171
Self-citationThe Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells
Cao, J., Mu, Q., & Huang, H. (2018) · Stem Cells International · doi:10.1155/2018/4217259 · Cited by 164
Therapeutic Targeting of the IGF Axis
Osher, E., & Macaulay, V. M. (2019) · Cells · doi:10.3390/cells8080895 · Cited by 153
“Secondly, the expression of IGF-2 is regulated by genomic imprinting, being expressed in normal tissues only from the paternal allele [27].”
BackgroundReceptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria
Haqqani, A. S., Bélanger, K., & Stanimirovic, D. B. (2024) · Frontiers in Drug Delivery · doi:10.3389/fddev.2024.1360302 · Cited by 153
Milman, S., Huffman, D. M., & Barzilai, N. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.014 · Cited by 150
“Certainly, the fact that adult rodents lack circulating IGF-2 has impaired progress in our understanding of this hormone (Bergman et al., 2013).”
Growth Hormone’s Links to Cancer
Boguszewski, C. L., & Boguszewski, M. C. D. S. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00166 · Cited by 146
Gao, W., Zhu, M., Wang, H., Zhao, S., Zhao, D., Yang, Y., Wang, Z., Wang, F., Yang, Z., Lü, X., et al. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.12.009 · Cited by 140
Hu, Z., Liu, W., Hua, X., Chen, X., Chang, Y., Hu, Y., Xu, Z., & Song, J. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315373 · Cited by 125
Insulin Resistance: The Increased Risk of Cancers
Szablewski, L. (2024) · Current Oncology · doi:10.3390/curroncol31020075 · Cited by 134
Effects of Prenatal Exposure to Endocrine Disruptors and Toxic Metals on The Fetal Epigenome
Bommarito, P. A., Martin, E., & Fry, R. C. (2017) · Epigenomics · doi:10.2217/epi-2016-0112 · Cited by 105
IGF2: Development, Genetic and Epigenetic Abnormalities
Sélénou, C., Brioude, F., Giabicani, É., Sobrier, M., & Netchine, I. (2022) · Cells · doi:10.3390/cells11121886 · Cited by 137
“The binding of IGF-I or IGF-II to IGF-1R leads to activation of the downstream MAP kinase and PI3 kinase signaling pathways [5,6].”
BackgroundWu, X., Zheng, X., Cheng, J., Zhang, K., & Ma, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117287 · Cited by 107
Vennin, C., Spruyt, N., Robin, Y. M., Chassat, T., Bourhis, X. L., & Adriaenssens, É. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.023 · Cited by 90
Holly, J. M. P., Biernacka, K. M., & Perks, C. M. (2019) · Cells · doi:10.3390/cells8101207 · Cited by 93
“The paternal imprinting of IGF-II is counterbalanced by the maternal imprinting of the IGF-II receptor gene in the mouse [84], although this does not appear to have been conserved in humans in whom the expression of this gene does not appear to be imprinted [85].”
BackgroundThe effects of maternal anxiety during pregnancy on IGF2/H19 methylation in cord blood
Mansell, T., Novakovic, B., Meyer, B., Rzehak, P., Vuillermin, P., Ponsonby, A.-L., Collier, F., Burgner, D., Saffery, R., Ryan, J., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.32 · Cited by 81
The Relationship of Insulin-Like Growth Factor 2 to Fetal Growth and Adiposity
Kadakia, R., & Josefson, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000443500 · Cited by 79
Ly, A., Ishiguro, L., Kim, D., Im, D., Kim, S., Sohn, K., Croxford, R., & Kim, Y. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.03.018 · Cited by 79
“Igf2 is a growth promoting hormone during gestation [55].”
BackgroundAkhatova, A., Jones, C., Coward, K., & Yeste, M. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01815-1 · Cited by 96
The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications
Escribano, Ó., Beneit, N., Rubio-Longás, C., López‐Pastor, A. R., & Gómez‐Hernández, A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1403206 · Cited by 80
“The IGF-II receptor (IGF-IIR), which is homologous to the cation-independent mannose-6-phosphate receptor, has a high affinity for IGF-II [65].”
BackgroundGarcía-Huerta, P., Troncoso-Escudero, P., Wu, D., Thiruvalluvan, A., Cisternas-Olmedo, M., Henríquez, D. R., Plate, L., Chaná‐Cuevas, P., Saquel, C., Thielen, P., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02183-1 · Cited by 72
Poręba, E., & Durzyńska, J. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108307 · Cited by 77
The Roles of H19 in Regulating Inflammation and Aging
Wang, B., Suen, C.-W. W., Ma, H., Wang, Y., Kong, L. D., Qin, D., Lee, W., & Li, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579687 · Cited by 79
Recent development in multizonal scaffolds for osteochondral regeneration
Yu, L., Cavelier, S., Hannon, B., & Wei, M. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.01.012 · Cited by 95
Zhang, W. B., Aleksic, S., Gao, T., Weiss, E. F., Demetriou, E., Verghese, J., Holtzer, R., Barzilai, N., & Milman, S. (2020) · Cells · doi:10.3390/cells9061368 · Cited by 64
“IGF-2, which has been implicated in disease [91,94], binds to the same IGFBPs and receptors as IGF-1, although at lower affinity, and signals via shared pathways with IGF-1 [95]; however, assessment of IGF-2 levels was out of scope of this study.”
BackgroundDing, W. J., Li, J., Singh, J., Alif, R., Vázquez-Padrón, R. I., Gomes, S. A., Hare, J. M., & Shehadeh, L. A. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv030 · Cited by 58
Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
Mancarella, C., Morrione, A., & Scotlandi, K. (2021) · Cells · doi:10.3390/cells10082075 · Cited by 53
“IGF2 secretion mainly depends on genetic imprinting, and it is expressed by the paternal chromosome under the control of the differentially methylated region (DMR) [26].”
BackgroundGenes and pathways associated with pregnancy loss in dairy cattle
Sigdel, A., Bisinotto, R. S., & Peñagaricano, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-92525-0 · Cited by 62
Lange, J. M., Takashima, J. R., Peterson, S., Kalapurakal, J. A., Green, D. M., & Breslow, N. E. (2014) · Cancer · doi:10.1002/cncr.28908 · Cited by 53
“Nonetheless, evidence was reasonably solid that irradiation of the entire chest with 12 Gy carried a significant hazard of early BC. Patients with WT who were treated for pulmonary metastases with 12 Gy of whole-chest RT are strong candidates for BC surveillance before age 40 years, after which routine mammographic su…”
BackgroundInfluentialChoi, Y., Lee, Y. A., Hong, Y., Cho, J., Lee, K., Shin, C. H., Kim, B.-N., Kim, J. I., Park, S. J., Bisgaard, H. F., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.105929 · Cited by 57
Tzankov, A., Hebeda, K. M., Kremer, M., Leguit, R. J., Orazi, A., van der Walt, J. D., & Gianelli, U. (2017) · Annals of Hematology · doi:10.1007/s00277-017-2947-4 · Cited by 52
“Moreover, the 8q12–13 region contains the IGF-2 regulator PLAG1 gene, which is rearranged in lipoblastomas [86, 87], while 6q25 contains the IGF2R gene, also known to be involved in carcinogenesis [88].”
BackgroundInsulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions
Garrett, S. M., Hsu, E., Thomas, J. M., Pilewski, J. M., & Feghali‐Bostwick, C. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225422 · Cited by 49
Hormone Signaling in the Testis
Smith, L. B., & Walker, W. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00016-8 · Cited by 59
Pio, L., O'Neill, A. F., Woodley, H., Murphy, A. J., Tiao, G. M., Franchi‐Abella, S., Fresneau, B. C., Watanabe, K., Alaggio, R., Lopez-Terrada, D. H., et al. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00620-7 · Cited by 56
Pian, L., Wen, X., Kang, L., Li, Z., Nie, Y., Du, Z., Yu, D., Zhou, L., Jia, L., Chen, J., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.013 · Cited by 51
Hoek, J., Steegers‐Theunissen, R. P. M., Willemsen, S. P., & Schoenmakers, S. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900696 · Cited by 50
Long noncoding RNA variations in cardiometabolic diseases
Dechamethakun, S., & Muramatsu, M. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.70 · Cited by 45
Genetics of Type 2 Diabetes: It Matters From Which Parent We Inherit the Risk
Lyssenko, V., Groop, L., & Prasad, R. B. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.233 · Cited by 44
Liu, J., Hu, X., Chen, J., Li, X., Wang, L., Wang, B., Peng, W., Yang, C., Li, Z., Chen, Y., et al. (2017) · Hepatology · doi:10.1002/hep.29340 · Cited by 41
“Previously, it was reported that IGF-2 promoted cell proliferation mainly by activation of insulin receptor (IR) and IGF-1 receptor (IGF-1R) signaling.((11,14)) Thus, we used an IR and IGF-1R inhibitor, linsitinib, to block the downstream of IGF-2 signaling pathway.”
BackgroundMethodEngström, W., Darbre, P. D., Eriksson, S., Gulliver, L., Hultman, T., Karamouzis, M. V., Klaunig, J. E., Mehta, R., Moorwood, K., Sanderson, J. T., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv030 · Cited by 43
Self-citationDetermination of IGFs and their binding proteins
Hjortebjerg, R., & Frystyk, J. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.08.010 · Cited by 41
van Doorn, J. (2020) · BioFactors · doi:10.1002/biof.1623 · Cited by 41
“Both IGFII and IGF-I can bind to these hybrid receptors, especially to hybrid IGF-IR/IR-A, leading to effects that are closer to those of IGF-IR.(17,18,22) The biological relevance of these hybrid receptors is unclear.”
BackgroundInfluentialGuo, Z., Zhao, Z., Yang, C., & Song, C. (2020) · Translational research · doi:10.1016/j.trsl.2020.07.003 · Cited by 38
RetractedFrom fever to immunity: A new role for IGFBP‐6?
Liso, A., Capitanio, N., Gerli, R., & Conese, M. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13738 · Cited by 39
“Moreover, IGF-II is involved in cardiovascular disease, likely because it has been shown to influence the size of atherosclerotic lesions.(33) Here we briefly review the main IGFBP-6 categories of actions:”
BackgroundJacob, Y., Anderton, R. S., Wilkie, J. C., Rogalski, B., Laws, S. M., Jones, A., Spiteri, T., Hince, D., & Hart, N. H. (2022) · Sports Medicine - Open · doi:10.1186/s40798-022-00522-y · Cited by 40
“IGF2 regulates cell proliferation, growth, migration, differentiation, and survival via its protein hormone [37].”
BackgroundGrowth hormone, insulin-like growth factor system and carcinogenesis
Boguszewski, C. L., Boguszewski, M. C. D. S., & Kopchick, J. J. (2015) · Endokrynologia Polska · doi:10.5603/ep.a2016.0053 · Cited by 39
“by activating downstream targets that lead to cellular proliferation [4, 5, 11].”
BackgroundInfluentialRNA-Binding Proteins in the Regulation of Adipogenesis and Adipose Function
Zhang, P., Wu, W., Ma, C., Du, C., Huang, Y., Xu, H., Li, C., Cheng, X., Hao, R., & Xu, Y. (2022) · Cells · doi:10.3390/cells11152357 · Cited by 38
“Insulin-like growth factor (IGF) 2 encodes a critical growth factor regulating growth and development [93].”
BackgroundNeuronal activity drives IGF2 expression from pericytes to form long-term memory
Pandey, K. R., Bessières, B., Sheng, S. L., Taranda, J., Osten, P., Sandovici, I., Constância, M., & Alberini, C. M. (2023) · Neuron · doi:10.1016/j.neuron.2023.08.030 · Cited by 38
Birth weight predicts aging trajectory: A hypothesis
Vaiserman, A. M. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.04.003 · Cited by 40
Reynolds, C. M., Perry, J. K., & Vickers, M. H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081729 · Cited by 34
“It has been hypothesised that the maternal and paternal expression patterns are balanced to offer maximal benefit to fetal growth whilst preventing excessive depletion of the mother’s resources [92].”
BackgroundRevealing the Potency of Growth Factors in Bovine Colostrum
Yalçıntaş, Y. M., Duman, H., López, J. M. M., Portocarrero, A. C. M., Lombardo, M., Khallouki, F., Koch, W., Bordiga, M., El-Seedi, H., Raposo, A., et al. (2024) · Nutrients · doi:10.3390/nu16142359 · Cited by 31
“IGF-2 is a critical regulator of cellular processes such as proliferation, migration, differentiation, and apoptosis (programmed cell death) [90].”
BackgroundCryo-electron Microscopic Analysis of Single-Pass Transmembrane Receptors
Cai, K., Zhang, X., & Bai, X. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01035 · Cited by 31
Zhang, Y. Q., Hu, J., Wang, H., Cui, J., Gao, S., Hoffman, A. R., & Li, W. (2016) · Oncotarget · doi:10.18632/oncotarget.10918 · Cited by 35
“Loss of IGF2 imprinting (LOI) with biallelic expression of IGF2 is a hallmark of many human tumors, especially childhood tumors [2, 3], and of cancer stem cells [16].”
BackgroundThe putative etiology and prevention of autism
Steinman, G. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.013 · Cited by 52
Karimi‐Zarchi, M., Zanbagh, L., Javaheri, A., Tabatabaei, R. S., Abbasi, H., Meibodi, B., Hadadan, A., Bahrami, R., Mirjalili, S. R., & Neámatzadeh, H. (2020) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2020.1745970 · Cited by 30
Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profiling
Slany, A., Meshcheryakova, A., Beer, A., Ankersmit, H. J., Paulitschke, V., & Gerner, C. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-41 · Cited by 34
“Apart from proteins indicating an activated inflammatory state of the tumor-associated fibroblasts, we also identified IGF-II, a known tumor promoter [60-62], in all kinds of tumor-associated fibroblasts (Figure 4).”
BackgroundMarked structural rearrangement of mannose 6-phosphate/IGF2 receptor at different pH environments
Wang, R., Qi, X., Schmiege, P., Coutavas, E. E., & Li, X. (2020) · Science Advances · doi:10.1126/sciadv.aaz1466 · Cited by 37
Let-7b Regulates Myoblast Proliferation by Inhibiting IGF2BP3 Expression in Dwarf and Normal Chicken
Lin, S., Luo, W., Ye, Y., Jebessa, E., Nie, Q., Li, Y., & Zhang, X. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00477 · Cited by 42
“It can bind to two types of cell surface receptors known as IGF1 receptor and IGF2 receptor, stimulate cell proliferation and inhibit apoptosis (Bergman et al., 2013).”
BackgroundAmenyah, S., Ward, M., McMahon, A., Deane, J., McNulty, H., Hughes, C., Strain, J., Horigan, G., Purvis, J., Walsh, C. P., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.09.011 · Cited by 31
“Polymorphisms of IGF2 have 267 been related to vascular risk factors and hypertension (32,33).”
BackgroundIntrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor
Forest, A., Amatulli, M., Ludwig, D. L., Damoci, C. B., Wang, Y., Burns, C. A., Donoho, G. P., Zanella, N., Fiebig, H., Prewett, M. C., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0279 · Cited by 32
“It is currently believed that IR-A rather than IR-B is implicated in tumor growth because it is frequently upregulated in tumor tissue (28) and has a greater affinity for IGF-II, a growth factor also known to be markedly overexpressed in some tumors as a result of LOI (35).”
BackgroundDevelopmental programming: the role of growth hormone
Oberbauer, A. M. (2015) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-015-0001-8 · Cited by 32
“It is hypothesized that the maternal and paternal expression are balanced to maximally promote fetal growth while preventing excessive depletion of the dam’s resources [10].”
BackgroundYang, N., Dong, B., Song, Y., Li, Y., Kou, L., Yang, J., & Qin, Q. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00222-z · Cited by 26
Ong, T., Trivedi, N., Wakefield, R., Frase, S., & Solecki, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-19063-7 · Cited by 26
Sheeba, C. J., Marslin, G., Revina, A. M., & Franklin, G. (2013) · Nanotechnology Reviews · doi:10.1515/ntrev-2013-0032 · Cited by 26
“In-depth reviews on IR, IGF, and IGF1R in cancer can be found elsewhere [37, 39, 63, 64].”
BackgroundCarter, R. C., Chen, J., Li, Q., Deyssenroth, M. A., Dodge, N. C., Wainwright, H., Molteno, C. D., Meintjes, E. M., Jacobson, J. L., & Jacobson, S. W. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13808 · Cited by 27
Pathophysiological Link between Insulin Resistance and Adrenal Incidentalomas
Higgs, J. A., Quinn, A. P., Seely, K. D., Richards, Z., Mortensen, S. P., Crandall, C. S., & Brooks, A. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084340 · Cited by 31
Chen, J., & Song, H. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.06.015 · Cited by 23
Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease
Mesaros, C., & Blair, I. A. (2016) · Clinical Proteomics · doi:10.1186/s12014-016-9121-1 · Cited by 27
“for cardiovascular disease [94–98].”
MiR-483 induces senescence of human adipose-derived mesenchymal stem cells through IGF1 inhibition
Shen, J., Zhu, X., & Liu, H. (2020) · Aging · doi:10.18632/aging.103818 · Cited by 28
“As pre-miR483 is located in intron 2 of the IGF2 transcript and encodes two mature miRNAs (miR-483-3p/miR-4835p) (Figure 2F), and IGF2 modulates the differentiation of stem cells [20, 21], we also measured the IGF2 expression using RT-qPCR.”
MethodAssociation of Copy Number Variation at Intron 3 of HMGA2 With Navel Length in Bos indicus
Aguiar, T. S., Torrecilha, R. B. P., Milanesi, M., Utsunomiya, A. T. H., Trigo, B. B., Tijjani, A., Musa, H. H., Lopes, F. L., Ajmone‐Marsan, P., Carvalheiro, R., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00627 · Cited by 28
“The main components of the IGF system, namely IGF1 and IGF2, are preferentially expressed after and before birth, respectively (Bergman et al., 2013).”
BackgroundGlucose-Regulated Protein 94 (GRP94): A Novel Regulator of Insulin-Like Growth Factor Production
Argon, Y., Bresson, S. E., Marzec, M., & Grimberg, A. (2020) · Cells · doi:10.3390/cells9081844 · Cited by 22
“In healthy newborns, IGF-II concentrations are highest in the fetus, about half that of adult levels, which are reached by 1 year of age and persist through life [17].”
BackgroundZhou, X., Tan, B., Gui, W., Zhou, C., Zhao, H., Lin, X., & Li, H. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00752-0 · Cited by 22
Bohnsack, R. N., Warejcka, D. J., Wang, L., Gillespie, S. R., Bernstein, A. M., Twining, S. S., & Dahms, N. M. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15179 · Cited by 21
A new p.(Ile66Serfs*93) IGF2 variant is associated with pre- and postnatal growth retardation
Rockstroh, D., Pfäffle, H., Duc, D. L., Rößler, F., Schlensog‐Schuster, F., Heiker, J. T., Kratzsch, J., Kieß, W., Lemke, J. R., Jamra, R. A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0601 · Cited by 21
CREG1 stimulates brown adipocyte formation and ameliorates diet‐induced obesity in mice
Hashimoto, M., Kusudo, T., Takeuchi, T., Kataoka, N., Mukai, T., & Yamashita, H. (2019) · The FASEB Journal · doi:10.1096/fj.201802147rr · Cited by 22
Atlas of imprinted and allele-specific DNA methylation in the human body
Rosenski, J., Peretz, A., Magenheim, J., Loyfer, N., Shemer, R., Gläser, B., Dor, Y., & Kaplan, T. (2025) · Nature Communications · doi:10.1038/s41467-025-57433-1 · Cited by 26
“However, the regulatory mechanisms underlying biallelic expression of IGF2 in the liver have not been elucidated 66,68 .”
InfluentialGuan, Y., Cai, B., Wu, X., Peng, S., Gan, L., Huang, D., Liu, G., Dong, L., Xiao, L., Liu, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06910-9 · Cited by 20
Kero, D., Cigić, L., Mikić, I. M., Galić, T., Ćubela, M., Vukojević, K., & Saraga‐Babić, M. (2016) · Organogenesis · doi:10.1080/15476278.2016.1197460 · Cited by 22
“On a cellular level, the effects of IGF-2 are similar to that of InsulinLike Growth Factor 1 (IGF-1) by promoting proliferation, differentiation, survival and migration of cells.(12,13) Functional versatility of IGF-2 must primarily be viewed within the context of IGF-axis, whose members such as Insulin-Like Growth Fa…”
MethodGutherz, O. R., Deyssenroth, M. A., Li, Q., Hao, K., Jacobson, J. L., Chen, J., Jacobson, S. W., & Carter, R. C. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113919 · Cited by 22
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
Abril‐Fornaguera, J., Torrens, L., Andreu-Oller, C., Carrillo-Reixach, J., Rialdi, A., Balaseviciute, U., Pinyol, R., Montironi, C., Haber, P. K., Río-Álvarez, Á. D., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0335 · Cited by 20
Different Pathways to the Lysosome
(2015) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2015.07.008 · Cited by 18
Liu, R., Tearle, R. G., Low, W. Y., Chen, T., Thomsen, D. A., Smith, T. P. L., Hiendleder, S., & Williams, J. L. (2021) · BMC Genomics · doi:10.1186/s12864-021-07667-2 · Cited by 23
Liao, J., Zeng, T.-B., Pierce, N., Tran, D. A., Singh, P., Mann, J. R., & Szabó, P. E. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108729 · Cited by 21
“We next explored the possibility of a pharmacological intervention in BWS. IGF2 signaling is mediated by the IGF1 receptor (IGF1R) (Baker et al., 1993; Bergman et al., 2013; Gicquel and Le Bouc, 2006).”
Kondo, T., Aoki, H., Otsuka, Y., Kawaguchi, Y., Waguri‐Nagaya, Y., & Aoyama, M. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.03.007 · Cited by 17
Roles of insulin-like growth factor II in regulating female reproductive physiology
Muhammad, T., Li, M., Wang, J., Huang, T., Zhao, S., Zhao, H., Liu, H., & Chen, Z. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1646-y · Cited by 18
Guang, L., Ma, S., Yao, Z., Song, D., Chen, Y., Liu, S., Wang, P., Su, J., Wang, Y., Luo, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-53820-2 · Cited by 22
Cancer Stem Cells: Emergent Nature of Tumor Emergency
Efremov, Y. R., Proskurina, A. S., Potter, E. A., Долгова, Е. В., Efremova, O. V., Taranov, O. S., Ostanin, A., Chernykh, E. R., Kolchanov, N. A., & Bogachev, S. S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00544 · Cited by 17
The InDel variants of sheep IGF2BP1 gene are associated with growth traits
Liu, H., Xu, H., Lan, X., Cao, X., & Pan, C. (2021) · Animal Biotechnology · doi:10.1080/10495398.2021.1942029 · Cited by 22
Harper, K. M., Tunc‐Ozcan, E., Graf, E. N., Herzing, L. B. K., & Redei, E. E. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.002 · Cited by 16
“Insulin-like growth factor 2 (Igf2) is involved in growth and development (for review see Bergman et al. (2013)).”
Schovanek, J., Cibickova, L., Ctvrtlik, F., Tudos, Z., Karasek, D., Iacobone, M., & Frysak, Z. (2019) · Journal of Cancer · doi:10.7150/jca.30472 · Cited by 16
“Increased expression of IGF-I, IGF-II, and IGF-IR has been determined in a variety of neoplasia, including brain tumors, mammary carcinoma, gastrointestinal cancer, including pancreatic carcinoma, and ovarian carcinoma [13, 14].”
BackgroundTran, P. V., Johns, M. E., McAdams, B. D., Abrahante, J. E., Simone, D. A., & Banik, R. K. (2020) · Molecular Pain · doi:10.1177/1744806920956480 · Cited by 15
Louveau, I., Vincent, A., Tacher, S., Gilbert, H., & Gondret, F. (2016) · Journal of Animal Science · doi:10.2527/jas.2016-0619 · Cited by 21
“Among the top 10 genes being underexpressed in low-RFI compared with high-RFI pigs (Table 6), expression levels of IGFBP5, PI15, MYPOP, SH3GL3, DCLK1, and SRPX were also affected by feed restriction within the high-RFI line.”
BackgroundInfluentialIGF2/IGF2R/Sting signaling as a therapeutic target in DSS-induced ulcerative colitis
Chen, L., Zhong, X., Cao, W.-Y., Mao, M., Liu, D., Liu, J., Zu, X., & Liu, J. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176122 · Cited by 17
lncRNA TUG1 as Potential Novel Biomarker for Prognosis of Cardiovascular Diseases
Haybar, H., Sadati, N. S., Purrahman, D., Mahmoudian‐Sani, M., & Saki, N. (2023) · Epigenomics · doi:10.2217/epi-2023-0242 · Cited by 16
Kashyap, S., Zeidler, J. D., Chini, C. C. S., & Chini, E. N. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109698 · Cited by 16
“On the other hand, IGFs are risk factors in obesity and cancer due to the potent proliferative activity [31, 34, 49, 50].”
BackgroundKnockdown of insulin-like growth factor 2 gene disrupts mitochondrial functions in the liver
Gui, W., Zhu, Y., Sun, S., Zhu, W., Tan, B., Zhao, H., Shang, C., Zheng, F., Lin, X., & Li, H. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab030 · Cited by 23
“It was possible that FFA not only activated gene expression but also activated the negative regulation of IGF2 (Bergman et al., 2013).”
BackgroundPark, K.-S., Rahat, B., Lee, H. C., Yu, Z., Noeker, J. A., Mitra, A., Kean, C. M., Knutsen, R. H., Springer, D., Gebert, C. M., et al. (2021) · eLife · doi:10.7554/elife.67250 · Cited by 16
Wiens, K. R., Wasti, N., Ulloa, O. O., & Klegeris, A. (2024) · Molecules · doi:10.3390/molecules29235525 · Cited by 16
Metadata
- Authors
- Bergman, D., Halje, M., Nordin, M., & Engström, W.
- Affiliations
- Swedish University of Agricultural Sciences (SE)
- ORCID
- Bergman, Daniel
- Venue
- Gerontology
- Publisher
- S. Karger AG
- Published
- 2012-12-20
- Volume
- 59
- Issue
- 3
- Pages
- 240-249
- ISSN
- 0304-324X (ISSN-L)
- 1423-0003
- OpenAlex
- W1976143235
- Cited by
- 260
- References
- 35
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 27 · 2023: 21 · 2022: 27 · 2021: 35 · 2020: 37 · 2019: 13 · 2018: 15 · 2017: 15 · 2016: 17 · 2015: 17 · 2014: 15 · 2013: 3
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Gerontology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- insulin-like growth factor II, genomic imprinting, loss of imprinting, overgrowth syndromes, cancer, breast cancer, colon cancer, lung cancer, cardiovascular disease, atherosclerosis, IGF-II receptor, apoptosis, tumor growth, geriatrics
- MeSH terms
- Animals, Cardiovascular Diseases, Disease, Female, Humans, Insulin-Like Growth Factor II, Male, Neoplasms, Protein Processing, Post-Translational, Receptor, Insulin, Signal Transduction, Receptor, IGF Type 1, Receptor, IGF Type 2, Genomic Imprinting, Insulin-Like Growth Factor Binding Proteins, Growth and Development, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.